Literature DB >> 23925688

Macrocytosis in Crohn's disease: a devastating blast.

Lennard Y W Lee1, Vidya Santharam, George Macfaul.   

Abstract

A 47-year-old woman with a 36-month history of Crohn's disease with one previous bowel resection treated with azathioprine was found to have a persistently raised mean corpuscular volume (MCV) on routine complete blood count testing. Despite vitamin B12 replacement, her MCV remained elevated. A bone marrow biopsy was performed, which demonstrated myelodysplastic syndrome. Macrocytosis is a common abnormality in patients with Crohn's disease, most commonly due to vitamin B12 deficiency and secondarily due to bacterial overgrowth. However, it is important to recognise that myelodysplastic syndrome is a common under-reported complication of azathioprine therapy. One-third of cases progress to acute myeloid leukaemia with poor prognosis. In patients with suspected myelodysplastic syndrome, azathioprine therapy should be immediately discontinued.

Entities:  

Mesh:

Year:  2013        PMID: 23925688      PMCID: PMC3762387          DOI: 10.1136/bcr-2013-200287

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

1.  Concurrent inflammatory bowel disease and myelodysplastic syndromes.

Authors:  G C Harewood; E V Loftus; A Tefferi; W J Tremaine; W J Sandborn
Journal:  Inflamm Bowel Dis       Date:  1999-05       Impact factor: 5.325

2.  Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

Authors:  Sonali M Smith; Michelle M Le Beau; Dezheng Huo; Theodore Karrison; Ronald M Sobecks; John Anastasi; James W Vardiman; Janet D Rowley; Richard A Larson
Journal:  Blood       Date:  2003-03-06       Impact factor: 22.113

3.  Secondary myelodysplastic syndromes following treatment with azathioprine are associated with aberrations of chromosome 7.

Authors:  Sabine Knipp; Barbara Hildebrandt; Jutta Richter; Rainer Haas; Ulrich Germing; Norbert Gattermann
Journal:  Haematologica       Date:  2005-05       Impact factor: 9.941

Review 4.  Azathioprine: association with therapy-related myelodysplastic syndrome and acute myeloid leukemia.

Authors:  Yok-Lam Kwong
Journal:  J Rheumatol       Date:  2010-01-15       Impact factor: 4.666

5.  Spontaneous remission in a patient with therapy-related myelodysplastic syndrome (t-MDS) with monosomy 7.

Authors:  B Renneboog; V Hansen; P Heimann; A De Mulder; F Jannsen; A Ferster
Journal:  Br J Haematol       Date:  1996-03       Impact factor: 6.998

  5 in total
  1 in total

1.  Hematologic indices as surrogate markers for monitoring thiopurine therapy in IBD.

Authors:  Uri Kopylov; Robert Battat; Amine Benmassaoud; Laurence Paradis-Surprenant; Ernest G Seidman
Journal:  Dig Dis Sci       Date:  2014-09-19       Impact factor: 3.199

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.